Advancing Vision Care and Inclusive Ophthalmology Research
Roche funds innovative and inclusive research to advance therapies, patient outcomes, and equitable access for serious retinal diseases in ophthalmology.
Funder: Roche
Due Dates (Anticipated): June 2026 (annual application deadline, projected)
Funding Amounts: Details not specified; typically supports research, clinical studies, and inclusion initiatives in ophthalmology.
Summary: Supports innovative, inclusive research and clinical studies to advance vision care and equitable access for patients with serious eye conditions.
Key Information: This is a forecasted grant; all dates are projected and subject to confirmation.
Description
Roche, through its ophthalmology-focused initiatives, seeks to improve vision care by supporting research that enhances patient experiences, promotes equitable access to treatments, and advances therapies for vision-threatening conditions. This program emphasizes scientific innovation and inclusivity, especially for underrepresented populations affected by diseases such as wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and geographic atrophy. Roche invests in both clinical research and the development of young scientists from diverse backgrounds, aiming to personalize healthcare and improve outcomes for all patients with serious retinal diseases.
